Atlas Trials

A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin

Clinical trial NCT01641575 · TERMINATED

Trial details

NCT number
NCT01641575
Sponsor
Clovis Oncology, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorNon-small-cell Lung CancerLung Cancer
Start date
2012-07-01
Primary completion
2013-05-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.